Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$979,900
+$640,260 QoQ
Shares Held
22,970
+228.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#254
of 712 holders
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Derivatives in SNY
reported options exposure · as of Jun 30, 2026CallValue
$426,600
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CSS LLC/IL holds $6,263,567 across 6 Drug Manufacturers - General names. SNY ranks #3 (15.6% of the industry book) .
All Filings in SNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $979,900 | 22,970 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $426,600 | 10,000 | Call | Sole | 2026-08-14 | |
| 2024-06-30 | $339,640 | 7,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $510,300 | 10,500 | Shares | Sole | 2024-05-15 | |
| 2021-12-31 | $976,950 | 19,500 | Call | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||